The cost-effectiveness of zemplar in the Netherlands

被引：0
|
作者：
Nuijten, MJ
Siegert, C
机构：
[1] Ars Accessus Medica Erasmus Univ, Rotterdam, Netherlands
[2] St Lucas Andreas Hosp, Amsterdam, Netherlands
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64336-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A7 / A8
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness model of Palivizumab in The Netherlands
    Nuijten, MJ
    Lebmeier, M
    Daalderop, P
    Wittenberg, W
    VALUE IN HEALTH, 2005, 8 (06) : A52 - A52
  • [2] Cost-effectiveness of statin therapy in The Netherlands
    Goes, ES
    VanHout, BA
    AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 (10): : LC3 - LC3
  • [3] Cost-effectiveness of rotavirus vaccination in the Netherlands
    Welte, R
    Jager, JC
    Van Duynhoven, Y
    De Wit, M
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1228 - 1228
  • [4] Cost-effectiveness of pertussis booster vaccination in the Netherlands
    Rozenbaum, Mark H.
    De Cao, Elisabetta
    Postma, Maarten J.
    VACCINE, 2012, 30 (50) : 7327 - 7331
  • [5] COST-EFFECTIVENESS OF DIAGNOSING AXIAL SPONDYLOARTHRITIS IN THE NETHERLANDS
    Webers, C.
    Grimm, S.
    Van Tubergen, A.
    Van Gaalen, F. A.
    Van der Heijde, D.
    Joore, M.
    Boonen, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 510 - 511
  • [6] Cost-effectiveness of atorvastatin compared to simvastatin in the Netherlands
    Severens, JL
    Prins, MH
    Monteban, HC
    VALUE IN HEALTH, 2003, 6 (06) : 671 - 671
  • [7] Cost-effectiveness of nonavalent HPV vaccination in the Netherlands
    Palmer, Cody
    Dolk, Christiaan
    Sabale, Ugne
    Wang, Wei
    Saxena, Kunal
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 312 - 323
  • [8] Cost-effectiveness of fosavancet in the treatment of osteoporosis in the Netherlands
    Jansen, J. P.
    Shavit, O.
    Bergman, G.
    Sen, S. S.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S259 - S259
  • [9] COST-EFFECTIVENESS OF INFANT PNEUMOCOCCAL VACCINATION IN THE NETHERLANDS
    Vemer, P.
    Postma, M. J.
    VALUE IN HEALTH, 2013, 16 (07) : A334 - A334
  • [10] COST-EFFECTIVENESS OF MENINSOCOCCAL B VACCINATION IN THE NETHERLANDS
    Zeevat, F.
    Joost, S.
    Westra, T. A.
    Wilschut, J. C.
    van Sorge, N.
    Boersma, C.
    Postma, M. J.
    VALUE IN HEALTH, 2022, 25 (12) : S177 - S177
12345